Revaccination should be considered for high-risk individuals, after weighing the benefits of vaccination against the potential risk of experiencing increased local or systemic adverse reactions.
Revaktsineerimist tuleb kaaluda riskigrupi patsientidel pärast vaktsineerimisest saadava kasu ja lokaalsete või süsteemsete kõrvaltoimete sagenemise riski hindamist.